MedPath

Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation

Completed
Conditions
Cardiovascular Diseases
Atrial Fibrillation, Persistent
Interventions
Procedure: Isolation of pulmonary veins
Procedure: Ablation by radiofrequency of low-voltage areas
Registration Number
NCT04045067
Lead Sponsor
French Cardiology Society
Brief Summary

This is a study evaluating the value of defragmentation of sinus rhythmic low voltage areas in addition to isolation of pulmonary veins in the removal of recurrent atrial fibrillation. The invasive procedure will be performed according to the procedures chosen by the rhythmologist and will in no way be modified by the patient's enrollment in the study. Similarly, the frequency of consultations, date and nature of the additional examinations will be defined by the physician, with the purpose of monitoring the patient.

Detailed Description

Radiofrequency ablation has become standard practice in the approach strategy for the symptomatic treatment of atrial fibrillation. The interest of substrate ablation, completing the isolation of the pulmonary veins is controversial. The usual technique for the ablation of recurrent atrial fibrillation is primarily a disconnection of the pulmonary veins, which can be accomplished by isolating the veins one by one or two by two. The isolation of the pulmonary veins is followed most often by a defragmentation of the atrium (ablation of the substrate). The defragmentation is guided by a map of fragmented potentials, made through a topography catheter, to locate the most abnormal areas that are the target of ablation. This strategy requires extensive ablation of the left atrium, with a long procedure time and repeated many radiofrequency shots. On the one hand there is a risk of complication related to the duration of intervention, but also in the longer term of occurrence of flutter scar. In addition to pulmonary vein isolation, the goal is to identify patients with sinus rhythm atrial arrhythmogenic substrate. Once the sinus rhythm has been restored by electrical cardioversion or spontaneously, a voltage map is carried out to identify the most abnormal (low voltage) areas, and intra-atrial fragmented potentials are identified, either spontaneously or spontaneously by the extra-stimulus method. Ablation of these abnormal areas may lead to better long-term results, limiting prolonged radiofrequency shots and complications associated with longer procedure times.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
212
Inclusion Criteria
  • Patients with persistent atrial fibrillation ablation, no specific indication restrictions or equipment used and regardless of the outcome of the procedure
  • Patients participating in a biomedical research can participate in this study.
Exclusion Criteria
  • Pregnant or lactating women can not participate in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 2Isolation of pulmonary veinsA group of patients who have pulmonary veins isolation alone, with low-voltage areas identified but the complementary defragmentation will not be carried out.
Group 1Isolation of pulmonary veinsA group of patients who have pulmonary vein isolation alone, without low-voltage areas identified.
Group 3Isolation of pulmonary veinsA group of patients who have pulmonary veins isolation, with low-voltage areas identified and the complementary defragmentation will be carried out.
Group 3Ablation by radiofrequency of low-voltage areasA group of patients who have pulmonary veins isolation, with low-voltage areas identified and the complementary defragmentation will be carried out.
Primary Outcome Measures
NameTimeMethod
Evaluation of the success rate of the proceduresmonth 18

Comparison between the 3 study arms of the number of new episodes of symptomatic atrial fibrillation

Secondary Outcome Measures
NameTimeMethod
Evaluation of the efficiency of the proceduresDay 1

Comparison between the 3 study arms of the duration of the intervention (in minutes), the duration of fluoroscopy (in minutes), rate of X-ray doses delivered during the procedure (in mGym² (milligray per meter²), the induction of atrial fibrillation at the end of the procedure or not.

Evaluation of the safety of the proceduresDay 1 / month 3 / month 6 / month 12 / month 18

Comparison between the 3 study arms of the number and type of events regarding the types of procedure: pericardial effusion, pericardial drainage, vascular complication, ischemic stroke, heart failure, acute coronary syndrome, new atrial fibrillation episode, death.

Trial Locations

Locations (9)

Centre Hospitalier Saint Joseph Saint Luc

🇫🇷

Lyon, France

Clinique de l'Infirmerie Protestante de Lyon

🇫🇷

Caluire-et-Cuire, France

Hôpital Privé Beauregard

🇫🇷

Marseille, France

Clinique Saint Gatien

🇫🇷

Tours, France

Clinique Ambroise Paré

🇫🇷

Neuilly-sur-Seine, France

Hôpital Universitaire Pitié Salpêtrière

🇫🇷

Paris, France

Hôpital Saint-Joseph

🇫🇷

Marseille, France

Centre Hospitalier Universitaire d'Angers

🇫🇷

Angers, France

Centre Cardiologique du Nord

🇫🇷

Saint-Denis, France

© Copyright 2025. All Rights Reserved by MedPath